ing the dose of radiation required. 3, 4, [11] [12] [13] However, among the challenges in achieving high-resolution soft-tissue imaging are the limited dynamic range and contrast resolution of current CBCT techniques. [13] [14] [15] The desire for a large field of view, in combination with the relatively large cross-sections required in clinical practice, requires that a CBCT apparatus has high detective quantum efficiency across a very broad range of exposure to the detector. The use of an additional contrast agent for increased soft tissue detection offers the potential ability for enhanced performance across the broad range of clinical applications of CBCT.
CBCT has been introduced into routine clinical practice as a new CT modality that provides cross-sectional images. [2] [3] [4] [5] 7 The flat panel detectors used in CBCT are much smaller than those used in multislice CT (MSCT). 2, 13 Therefore, these detectors have physical features that provide excellent visualization in high-contrast structures with superior spatial resolution compared to MSCT. [14] [15] [16] [17] However, smaller detector elements receive proportionately lower photon flux, resulting in inferior contrast resolution. 2, 13, 17 The use of CBCT has therefore been limited due to low contrast resolution in soft tissue imaging. Only a few publications have been published comparing CBCT with MSCT regarding the diagnostic capacities of these modalities in soft tissue imaging. 14, 15, 17 For the most part, intracranial hemorrhages have been investigated. 14, 15, 18 The use of intravenous (IV) contrast-enhancing materials during CBCT acquisition has rarely been reported, although some authors have used IV contrast enhancers to visualize intraabdominal tumors or vascular lesions. 18, 19 Despite its limited soft tissue contrast resolution, CBCT provides substantially superior spatial resolution in comparison with MSCT. [14] [15] [16] [17] The superior spatial resolution of CBCT could lead to the enhanced visualization of soft tissue contrasts and small vascular structures, although a contrast-enhancing medium may be necessary to ensure substantial opacification and visibility of soft tissue and vessels. CBCT combined with the IV administration of a contrast-enhancing medium might, therefore, be a new tool in the diagnostic workup of soft tissue lesions in the oral and maxillofacial region. The purpose of this study was to evaluate the feasibility of visualizing soft tissue contrasts and vascular structures with contrast-enhanced CBCT (CE-CBCT) after IV injection of a contrast-enhancing medium in an experimental animal model.
Materials and Methods
The study was approved by the Animal Protection Committee of Kyung Hee University. Six New Zealand white rabbits (4-5 kg body weight) were used for this animal model. No previous studies have described the proper parameters of injecting the contrast medium (Iopamiro ® , Ilsung Co., Seoul, Korea) for CBCT imaging. Therefore, experiments were performed using 2 mL/kg body weight, followed by a 6-mL saline flush with an injection rate of 1 mL/s via the ear vein or femoral vein under general anesthesia, which was performed with a subcutaneous injection of ketamine (80 mg/kg body weight) and Xylazine (7 mg/kg body weight) (Fig. 1) . A preliminary examination was carried out to evaluate the effect of contrast enhancement in obtaining conventional radiography after the IV injection of the contrast medium. After the preliminary assessment, the following protocol was established for administering the contrast media for CBCT imaging. Three techniques were established for administering the contrast media. In Type 1, a 10-mL injection was administered for 10 seconds during CBCT scanning. Type 2 involved a 10-mL injection with a delay time of 30 seconds before CBCT scanning. Type 3 involved a 5-mL injection with a delay time of 20 seconds before CBCT scanning, combined with a 5-mL continuous injection during CBCT scanning.
Imaging was performed with a CBCT apparatus (Alphard Vega, Ashahi Roentgen Co., Kyoto, Japan). The exposure parameters were set at a tube voltage of 80 kVp, a tube current of 6 mA, and an exposure time of 17 seconds. The exposure area was set to be 200 mm in diameter and 179 mm in height, with a voxel size of 0.39 mm. In this device, the X-ray source rotates 360 degrees around the ─ 32 ─ Intravenous contrast media application using cone-beam computed tomography in a rabbit model objects being imaged. The rabbits were immobilized by using specifically designed equipment that was constructed from acrylic resin for animal fixation (Fig. 2) .
We created an experimental artificial soft tissue lesion model that has never been described previously. No previous model had been used to simulate and investigate soft tissue lesions in the salivary gland for a CBCT study in combination with the evaluation of vascular structures, such as the external carotid artery. The artificial lesions in the salivary gland were created in the submandibular glands (SMGs) of six New Zealand white rabbits, according to the following procedure. A vertical skin incision about 5 cm in length was made and both SMGs were exposed under general anesthesia, which was performed with a subcutaneous injection of ketamine (80 mg/kg body weight) and Xylazine (7 mg/kg body weight). Fatty tissue was obtained from the adjacent fatty space that exists along the neck muscles. The transplantation of autologous ─ 34 ─ Intravenous contrast media application using cone-beam computed tomography in a rabbit model fatty tissue into the salivary gland was performed after the incision of the SMGs and suturing using 4-0 absorbable surgical sutures. The skin was then closed using a 3-0 Polysorb running suture (Fig. 3) . The CBCT images were post-processed using a dedicated workstation and OnDemand 3D software (CyberMed Inc, Seoul, Korea). We performed volume-rendering reconstruction (VRT) for three-dimensional imaging. Coronal maximum intensity projection (MIP) images with a 5-mm slice thickness and 2.5-mm interposition were reconstructed in order to visualize the external carotid arteries and nutrient vessels of the SMGs. Axial and coronal multiplanar reconstructions (MPRs) with a 0.39-mm slice thickness were reformatted and used to perform measurements (Fig.  4) . We tried to find matching slice positions, which was not entirely possible because each rabbit was positioned slightly differently. Post-image processing was performed on each dataset. The window level and width of CBCT images were set at 0 and 1,000, respectively, in order to clarify the SMGs and the adjacent fatty space (Fig. 5) . The reconstructions were anonymized for evaluation. Two experienced oral and maxillofacial radiologists independently evaluated the CBCT images for soft tissue contrast and vascular structure anatomy, using standard tools and software at a dedicated workstation.
Results
First, we conducted a preliminary examination to evaluate the effect of IV contrast enhancement on obtaining conventional radiography after the IV injection of the contrast medium. Static radiography images were taken after IV injection of the contrast medium according to the various experimental methods. One method involved a radiographic exposure with a delay time of 30 seconds after the IV injection of 10 mL of contrast medium. In the second method, a radiographic exposure was performed in combination with a continuous injection of 5 mL of contrast medium, 30 seconds after a 5-mL injection. The former radiograph revealed the circulation of contrast media through the heart, with weak visualization of the carotid arteries. The latter radiograph revealed an accumu-─ 36 ─ Intravenous contrast media application using cone-beam computed tomography in a rabbit model Fig. 9 . A. The CBCT images show the difference of value of contrast density before and after contrast media administration for the artificial lesion in salivary gland by transplantation of autogenous fatty tissue. B. The graph shows the comparison of contrast density between non-enhancement and type 3 contrast enhancement in salivary gland and artificial fatty lesion on the CBCT image. (Fig. 6 ). Therefore, we were able to adopt a study protocol investigating different administrations of the contrast medium for CBCT, as discussed above. CBCT imaging data was obtained from every animal in all of the experimental conditions that we investigated. Post-image processing was performed successfully for all datasets. Opacification of the vascular structures and contrast enhancement of the SMGs were evaluated in MPRs by calculating the contrast density in the region of interest in the CBCT image. The mean contrast density of the SMGs in non-enhanced CBCT was 22, with a standard deviation (Std) of 28, a minimum (Min) value of -45 and a maximum (Max) value of 83 (Fig. 7A) . The mean contrast density value of Type 1 CE-CBCT images was 144 (Std, 31; Min, 31; Max, 197) (Fig. 7B) . The mean contrast density value of Type 2 CE-CBCT images was 215 (Std, 35; Min, 134; Max, 301) (Fig. 7C ) and the mean contrast density value of Type 3 CE-CBCT images was 364 (Std, 39; Min, 254; Max, 471) (Fig. 7D) .
The anatomy of the carotid arteries and the nutrient vessels to the SMGs in the neck region was clearly visible in all modalities. Subsequently, both reviewers determined that all VRT images obtained by CBCT were of good diagnostic quality. Type 3 reconstructed CBCT MIP images were assessed to evaluate variation among the different methods of administrating the contrast medium. The delineation of vessels and SMGs was sharper in Type 3 images, and therefore the borders of the nutrient vessels and the anatomy of the SMGs were much more visible, indicating sharp contrast enhancement. The results of the measurements are given in Figure 8 .
An artificial soft tissue lesion was successfully created in all six animals. None of the animals presented with any clinical abnormalities. The contrast enhancement of soft tissue was observed in all administrations of contrast medium. However, the optimal administration of contrast media for CE-CBCT was a 5-mL injection before exposure with a continuous 5-mL injection during scanning (Type 3 CE-CBCT). The contrast density values for the artificial lesion within the SMGs and the vascular structures of the carotid arteries and the nutrient vessels were nearly identical in all three modalities. However, sufficient opacification of the soft tissues and vascular structures only occurred in the Type 3 CE-CBCT procedure. The anatomy of the artificial soft tissue lesions was clearly visible. The contrast density value of the SMGs changed from 32 in non-enhanced CBCT to 319 in Type 3 CE-CBCT, while the contrast value of the artificial fatty lesions changed from -154 in non-enhanced CBCT to -125 in Type 3 CE-CBCT. The results of the measurements are given in Figure 9 .
Discussion
CBCT using a flat panel detector is an alternative method of obtaining cross-sectional images. [1] [2] [3] [4] The idea of performing CBCT with the IV administration of a contrast medium in order to improve its imaging capacity is a straightforward development of existing techniques.
18-21
The well-known superior spatial resolution of CBCT may facilitate the visualization of small vascular structures or soft tissue in oral and maxillofacial lesions. 21 However, its inferior soft tissue resolution might limit the observable contrast between opacified vascular structures and the surrounding tissue. 17, 19, 20 To the best of our knowledge, no study has yet been published evaluating CBCT images of salivary gland lesions after the IV administration of a contrast-enhancing medium. Limited studies have been performed assessing the administration and visualization of IV contrast material in CBCT. [19] [20] [21] The present study provided an in vivo evaluation of CBCT in an animal model. Our idea was to show that the visualization of vascular structures using CE-CB CT should be possible, despite the limited contrast resolution of CBCT. Our observations indicated that the visualization of the investigated structures appeared nearly identical in all imaging modalities including VRT, MIP, and MPR. Although small structures were investigated, we were at the margins of diagnostic accuracy. Therefore, we do not suggest that any one modality was superior to the others. The three modalities provide an almost equal visualization of the dimensions of the investigated structures. However, structures in the reconstructed VRT images were relatively hard to distinguish, compared to those in the MIP and MPR images. The margins of the SMGs and vascular structures were more sharply delineated in the MPR and MIP reconstructions of CBCT imaging, probably due to its superior spatial resolution and limited soft tissue resolution. The dosage and timing of contrast material administration were critical. Although no previous study has indicated the proper techniques for this experimental setup, we used a standard dose of 2 mL/kg body weight and consistent CBCT injection parameters. Our aim was to demonstrate that a standard dose and administration method of contrast material would provide sufficient opacification of vascular structures, allowing the arteries and soft tissues to be visualized. The dose of 2 mL/kg body weight is comparable to injection protocols in human beings and has also been used in other animal studies on rabbits. 22 Contrast medium administration using the Type 3 protocol (5-mL injection and 20-second delay time, with a 5-mL continuous injection during CBCT scanning) was sufficient despite the acquisition time of 17 seconds in the CBCT apparatus. The contrast enhancement was visible in all animals. It may be useful for future studies to investigate the optimal timing, amount, and concentration of contrast material. An advantage of CBCT technology is that it involves a reduced radiation dose compared to conventional CT. [23] [24] [25] However, CBCT images have several types of noise, especially in the central portion of the field of view. In addition, CBCT images are low-contrast, and motion artifacts, which are mainly caused by inadequate breath-holding, can cause the image quality to deteriorate. 17, 26 Artifacts from the catheter, contrast material in the vessels, or densely accumulated iodized contrast medium can also been seen. 27, 28 An advanced algorithm and a faster scanning protocol may be needed to improve the image quality by reducing these image artifacts. 27 Therefore, further comparative studies of CBCT, MSCT, and other imaging techniques are necessary to evaluate the radiation dose and diagnostic quality with regard to the visualization of vascular structures and soft tissue lesions before this new method can be recommended to patients as a routine procedure. Evidence seems to suggest that CBCT is associated with either a higher or lower radiation dose than MSCT, depending on the CBCT program used. 29, 30 This also needs further investigation. Our study had multiple shortcomings. The sample size of six rabbits was small, but sufficient to demonstrate feasibility in this preliminary study. Signal ratios were usually used to compare contrast values. Because the measurement of Hounsfield units is not yet possible in CBCT, it was not possible to provide a comparison of signal ratios. Thus, our impressions of CBCT contrast values were somewhat subjective. Another limitation of the study may be the lack of histological tests to validate the measurements. CE-CBCT has not been broadly applied for clinical purposes,, but broader implementation would be necessary to optimize contrast application in patients.
In conclusion, this study demonstrated the feasibility of CE-CBCT used instead of simple CBCT in a rabbit model. Despite its limited soft tissue contrast resolution, it was possible to visualize the opacification of vascular structures and the presence of an artificial soft tissue lesion with sufficient contrast to the surrounding structures. The vascular structures and soft tissue lesions were clearly visualized in the CE-CBCT images, which probably due to the superior spatial resolution of this technique.
